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Objective To estimate the relation of precisely measured
regional body composition with peripheral and central
arterial stiffness in the elderly.
Methods We investigated 648 participants (mean age
69.0 6 6.0 years) of the Hoorn Study, a population-based
cohort study. Trunk fat, leg fat, trunk lean and leg lean
mass were distinguished by dual-energy X-ray
absorptiometry. We used ultrasound to measure the
distensibility and compliance of the carotid, femoral and
brachial arteries, and carotid Young’s elastic modulus, as
estimates of peripheral stiffness. As estimates of central
stiffness we measured carotid–femoral transit time, aortic
augmentation index and systemic arterial compliance.
Results After adjustment for sex, age, height, mean arterial
pressure, leg lean and leg fat mass, a larger trunk fat mass
was consistently associated with higher peripheral arterial
stiffness (standardized beta () of mean Z-scores of all
three large arteries 20.24, P < 0.001). In contrast, larger leg
fat mass ( 0.15, P 0.009) and leg lean mass ( 0.09,
P 0.20) were associated with lower peripheral arterial
stiffness. Trunk or leg fat mass were not associated with
central arterial stiffness. Leg lean mass, however, was
consistently associated with lower central arterial stiffness
( 0.29, P < 0.001).
Conclusions Trunk fat mass may have adverse effects on
peripheral, but not on central arterial stiffness, while leg fat
was not harmful and may have a slight protective effect.
Larger leg lean mass was the most important determinant
of lower central arterial stiffness. These results provide a
pathophysiological framework to explain not only the
higher cardiovascular risk in individuals with larger trunk
fat mass, but also the reduced cardiovascular risk in
individuals with larger leg lean and fat mass. J Hypertens
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Introduction
Obesity, and in particular abdominal fat accumulation,
is an independent risk factor for cardiovascular disease
[1,2]. In contrast, peripheral fat and muscle may
independently contribute to a lower risk for cardio-
vascular disease [3–9]. The mechanisms underlying
these contrasting associations are not completely under-
stood.
Increased arterial stiffness may represent a pathway
through which obesity may lead to cardiovascular
disease. Arterial stiffening impairs the ability of the
arterial system to handle the pressure boost at systole,
which leads to increased systolic blood pressure, de-
creased diastolic blood pressure, increased left ventricu-
lar mass, and decreased diastolic coronary perfusion
[10]. Arterial stiffness is known to increase with ageing,
hypertension and with deteriorating glucose tolerance
status. Nevertheless, arterial stiffness is not uniform
along the arterial tree, and depends on the type of
artery (e.g. elastic versus muscular). The response to
ageing and other risk factors is also different along the
arterial tree [11–15].
Several studies have considered obesity or fat distribu-
tion as determinants of arterial stiffness [16–24]. The
results, however, have been inconsistent, which may be
due to the limited number of subjects [16–19,21,24], or
because stiffness has been estimated in only one specific
artery [16,18–21,23,24]. In addition, usually only anthro-
pometric measures [16,18,22,24] or bio-impedance [20]
have been used to assess obesity or body composition,
which are relatively inaccurate methods, in particular in
obese and elderly individuals [25–27].
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We hypothesized that abdominal fat may be associated
with higher arterial stiffness, and that, in contrast,
peripheral fat and lean mass may be associated with
lower arterial stiffness. To systematically investigate
this, we examined data of a large, population-based
study. Body composition was estimated by dual-energy
X-ray absorptiometry (DXA), which enables the distinc-
tion of central and peripheral fat and lean mass [9].
Arterial stiffness was estimated from the distensibility
and compliance of three large (carotid, femoral and
brachial) arteries (as estimates of peripheral arterial
stiffness), as well as from carotid–femoral transit time,
aortic augmentation index and systemic arterial com-
pliance (as estimates of central arterial stiffness).
Methods
Subjects
The Hoorn Study is a population-based cohort study of
glucose metabolism and its complications, which started
in 1989 [28]. It consisted of 2484 men and women aged
50–75 years at baseline. In 2000–2001, a third examina-
tion was carried out among surviving participants who
gave their permission to be re-contacted. We invited all
participants who had diabetes, as determined by a 75-g
oral glucose tolerance test (OGTT) or by diabetes
treatment (n ¼ 176), at the second examination of the
entire cohort in 1996–1998 [29]. We also invited a
random sample of participants who had normal glucose
tolerance (n ¼ 705) or impaired glucose tolerance
(n ¼ 193) in 1996–1998. Of 1074 individuals invited,
648 (60.3%) persons participated. The main reasons for
not participating in the 2000–2001 follow-up examina-
tion were lack of interest (30%) or co-morbidity (23%).
Other reasons were high age (7%), unwillingness to
travel (6%), participation considered too time-consum-
ing (6%), and miscellaneous reasons (15%), while 13%
gave no reason. For the present study cross-sectional
data of this examination were analysed. The Ethical
Review Committee of the VU University Medical
Center approved the study protocol and all participants
gave their written informed consent.
Body composition
Total body fat percent, and fat and lean soft-tissue
mass of the trunk and legs were determined by whole-
body dual-energy X-ray absorptiometry (DXA) (QDR-
2000, software version 7.20D; Hologic, Brussels, Bel-
gium), as previously described [9]. All DXA scans were
performed and read by one investigator.
Peripheral arterial stiffness
The methods of obtaining peripheral arterial stiffness
measures within the Hoorn Study have been described
before [12]. Briefly, we obtained the diameter (D) and
distension (˜D) of the right common carotid, the right
common femoral and the right brachial arteries, and the
intima–media thickness (IMT) of the right carotid
artery by ultrasound. Brachial systolic and diastolic
pressures were assessed in the left upper arm. Brachial
pulse pressure (PP) and brachial mean arterial pressure
(MAP) were calculated. PP at the carotid and femoral
arteries was calculated by the distension waveform
calibration method, which is more accurate than using
brachial PP [30,31]. All ultrasound measurements were
performed by a single sonographer.
Distensibility (DC) and compliance (CC) coefficients
were calculated from D, ˜D and PP [32]. Distensibility
reflects the elastic properties of an artery, whereas the
compliance reflects the buffering capacity of the artery.
From carotid IMT, D and DC, we calculated Young’s
elastic modulus (E), an estimate of the intrinsic elastic
properties of the vessel wall.
Central arterial stiffness
The carotid–femoral transit time (TT) is the travelling
time of a pressure wave from the common carotid to
the femoral artery, a measure of the aortic (thoracic–
abdominal) compliance. It is closely related to the
carotid–femoral pulse wave velocity [33,34], as meas-
ured by the length of the carotid–femoral arterial
segment divided by carotid–femoral TT. However, as
non-invasive measurement of this length may introduce
error, in particular in obese [32] and older patients [34],
we chose to use the carotid–femoral TT, and adjust for
height in the statistical analyses. We determined the
carotid–femoral TT by continuous measurement of the
diameter (distension curves) of the right carotid artery
and the right femoral artery [12]. We then determined
the average time delay (mean of three recordings of
4 s/artery) from the ECG trigger to 10% of the ascend-
ing slope of the distension curve and subtracted the
carotid value from the femoral value to obtain the
femoral–carotid TT [35].
Radial applanation tonometry was used to obtain the
aortic augmentation index (AI), and was performed
with a piezo-resistive pressure transducer (Millar SPT-
301; Millar Instruments Inc., Houston, Texas, USA)
connected to an arterial waveform analysis device
(Sphygmocor; AtCor Medical Ltd., Moreton-in-Marsh,
UK). The AI represents the extra pressure boost with
which the left ventricle must cope due to (early) wave
reflection. The AI was calculated as augmented pres-
sure divided by (tonometrically derived) central pulse
pressure.
Systemic arterial compliance reflects the overall buffer-
ing capacity of the arterial system, but mainly of the
proximal aorta [33,36]. Systemic arterial compliance
(SAC) in ml/mmHg was determined according to two
methods. The first method (SAC1) was the time-decay
method based on the Windkessel model [37] and used
data obtained by applanation tonometry (see above).
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
2340 Journal of Hypertension 2004, Vol 22 No 12
The second method used the ratio of stroke volume to
aortic pulse pressure to estimate systemic arterial com-
pliance (SAC2) [38]. Here we chose to estimate the
aortic pulse pressure by calibration of carotid pulse
pressure [12], because studies have suggested that this
may be the most accurate estimate [31,39,40], and data
on this estimate were available for a larger number of
persons in our study. Stroke volume was calculated as
the ratio of cardiac output and heart rate. Cardiac
output (ml/s) was measured by pulse wave Doppler
echocardiography (3.5 MHz transducer, HP 5500; Mas-
sachusetts, USA) of the left ventricular outflow tract.
All measurements were performed by one investigator.
Additional measurements
We determined fasting glucose, insulin, post-load glu-
cose after a 75-g OGTT, high-density (HDL) and low-
density (LDL) lipoprotein cholesterol, triglycerides,
serum creatinine, body mass index (BMI), waist cir-
cumference, and prior cardiovascular disease, as de-
scribed elsewhere [9,41,42]. We obtained self-reported
information on health status, medical history, current
medication use, physical activity (min/week), alcohol
intake (g/day), macronutrient intake (energy %) and
current smoking (yes/no) by questionnaires.
Statistical methods
Multiple linear regression analyses were performed to
investigate the association between body composition
(determinants) and estimates of arterial stiffness (out-
comes). First we considered trunk fat, trunk lean, leg
fat and leg lean mass together as central determinants
of peripheral and central arterial stiffness, adjusted for
age, gender, height and MAP. In a second model we
additionally adjusted for glucose tolerance status. Next,
we adjusted for other potential confounders by adding
these variables to the regression models. Effect mod-
ification by gender was tested by adding product terms
to the models. Effect modification was considered
statistically significant if P , 0.05. We considered the
stability of the regression models to be disturbed by
multi-colinearity if the tolerance was , 0.1. Standar-
dized betas are reported. A standardized beta of 0.1
indicates that when the independent variable increases
by 1 SD, the dependent variable increases by 0.1 SD.
A summarizing peripheral stiffness variable was con-
structed by means of Z-scores. We calculated (sex-
specific) Z-scores for each peripheral stiffness measure
(DC, CC and E) of each artery, and multiplied the Z-
score of E by –1. A Z-score is calculated as the
individual value minus the mean value in the study
population, divided by the standard deviation. We then
performed regression analyses using the mean of the
seven Z-scores as dependent variable. Similarly, we
constructed a summarizing score for central stiffness
measures (AI, SAC1 and SAC2). The Z-scores were
multiplied by –1, except for AI. Because carotid–
femoral TT was available in fewer persons, we did not
include this measure in the mean Z-score for central
arterial stiffness. All statistical analyses were performed
using SPSS for Windows (version 10.1.0; Chicago,
Illinois, USA).
Results
Table 1 shows characteristics of the study population.
Of the 648 participants, 25 persons were excluded
because of missing DXA data. Another 139 participants
did not take part in the ultrasound examination and
were also excluded from all analyses. The main reason
for missing ultrasound data was poor definition of the
arterial wall due to obesity; other reasons were logistical
and technical.
Table 2 shows estimates of peripheral and central
arterial stiffness of the study population. Data on
central arterial stiffness were mainly missing due to
device availability. Nevertheless, subjects with missing
data were statistically significantly older, had higher
BMI and total fat percentage, and were more likely to
have diabetes (data not shown).
Associations of body composition with peripheral arterial
stiffness
After adjustment for the other body composition vari-
ables, trunk fat mass was consistently associated with
larger arterial stiffness as estimated from DC, CC and
E (Model 1, Table 3). Addition of trunk lean mass to
this model did not change the results of the other
variables, and because of the strong correlation between
trunk lean and leg lean mass (Pearson’s r ¼ 0.93), the
model including trunk lean mass became disturbed by
multi-colinearity. Therefore, Model 1 is shown without
adjustment for trunk lean mass. In contrast to trunk fat
mass, larger leg fat mass was associated with lower
femoral stiffness. Larger leg lean mass was also asso-
ciated with higher compliance in the femoral and
brachial arteries. Associations with fat mass were gen-
erally stronger in men than in women, and associations
with lean mass were stronger in women, but there was
no statistically significant effect modification by gender,
except for the association between leg fat mass and
carotid E (P interaction ¼ 0.03). The independent
associations of trunk fat, leg fat and leg lean mass with
peripheral arterial stiffness are further summarized and
illustrated in Figures 1 and 2. We performed regression
analyses using the mean of the seven Z-scores as
dependent variable (similar to models in Table 3) and
plotted the standardized betas in Figure 1. In Figure 2
we show the results for each peripheral artery sepa-
rately.
Additional adjustment of Model 1 for lifestyle (physical
activity, smoking, alcohol or nutrient intake), compo-
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Body composition and arterial stiffness Snijder et al. 2341
nents of the metabolic syndrome (LDL- and HDL-
cholesterol, triglycerides, hypertension), and other
cardiovascular risk factors (serum creatinine, (micro-)
albuminuria and prior cardiovascular disease) did not
materially change the associations (data not shown).
Adjustment for HbA1c, insulin, fasting or post-load
glucose attenuated the associations, in particular in the
femoral and brachial arteries (data not shown). After
adjustment for insulin and fasting and post-load glucose
levels together, all associations weakened and most
became non-significant, except for the associations with
carotid E, and femoral CC (data not shown). Model 2
shows the independent associations of trunk fat, leg fat
and leg lean mass with peripheral stiffness after adjust-
ment for glucose tolerance status.
Table 4 provides insight into which elements of the
peripheral arterial stiffness estimates (i.e. D, ˜D, PP or
IMT) contributed to the associations shown in Table 3.
The associations were mainly determined by D or ˜D,
or by both in the femoral artery, but not by PP.
There was no statistically significant effect modification
by gender. None of the regression models were dis-
turbed by multi-colinearity.
Associations of body composition with central arterial
stiffness
Trunk fat mass was not associated with higher central
arterial stiffness, except for SAC2 (Table 5). Leg lean
mass was consistently associated with lesser central
arterial stiffness. There was no statistically significant
effect modification by gender. The independent asso-
ciations of trunk fat, leg fat and leg lean mass with
central arterial stiffness are further illustrated in Figure
3, with the mean Z-scores of each central stiffness
estimate as dependent variables. Because carotid–
femoral TT was available in fewer persons (see Table
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Table 1 Characteristics of the study population
Men (n ¼ 244) Women (n ¼ 240) P
Age (years) 69.1  5.9 69.0  6.3 0.98
Anthropometry
Height (cm) 175.9  6.1 163.5  6.4 , 0.01
Weight (kg) 82.1  10.1 70.4  9.7 , 0.01
BMI (kg/m2) 26.5  3.0 26.3  3.2 0.48
Waist circumference (cm) 97.6  9.1 87.9  10.0 , 0.01
DXA
Total body fat percent (%) 27.5  5.9 40.0  6.1 , 0.01
Total fat mass (kg) 22.5  6.7 28.2  7.4 , 0.01
Total lean mass (kg) 55.3  5.8 39.2  4.5 , 0.01
Trunk fat mass (kg) 12.2  4.6 13.4  4.7 , 0.01
Trunk lean mass (kg) 27.9  2.8 20.1  2.3 , 0.01
Leg fat mass (kg) 6.3  1.8 9.9  2.8 , 0.01
Leg lean mass (kg) 17.5  2.3 12.4  1.8 , 0.01
Metabolic variables
Systolic blood pressure (mmHg) 138.9  16.6 142.6  21.1 0.03
Diastolic blood pressure (mmHg) 77.1  8.2 74.9  9.3 , 0.01
Pulse pressure (mmHg) 61.8  12.4 67.7  16.3 , 0.01
Mean arterial pressure (mmHg) 97.7  10.2 97.5  12.1 0.84
Hypertension (%) 64.3 65.3 0.83
LDL-cholesterol (mmol/l) 3.50  0.85 3.87  0.92 , 0.01
HDL-cholesterol (mmol/l) 1.26  0.31 1.62  0.43 , 0.01
Triglycerides (mmol/l) 1.3 (1.0–1.7) 1.2 (0.9–1.7) 0.40
Fasting glucose (mmol/l) 6.15  1.21 6.09  1.44 0.64
Post-load glucose (mmol/l)a 6.92  2.59 7.14  2.46 0.36
Fasting insulin (pmol/l) 57.0 (40.3–75.0) 53.0 (39.0–79.5) 0.76
Glycated haemoglobin (%) 5.91  0.72 6.01  0.67 0.15
IGM (%) 28.8 24.5 0.28
DM (%) 22.2 21.9 0.94
Prior cardiovascular disease (%) 44.3 44.0 0.95
(Micro-) albuminuria (%) 16.8 8.8 , 0.01
Serum creatinine (mol/l) 130.3  17.1 86.8  9.4 , 0.01
Lifestyle
Current smokers (% yes) 18.0 12.5 0.09
Physical activity (min/week) 1110 (609–1300) 1328 (840–2040) 0.02
Alcohol drinker (%) 97.9 91.5 , 0.01
Alcohol intake (g/day) 12.7 (3.7–28.7) 4.2 (0.7–12.8) , 0.01
Fat intake (% energy intake) 35.2  5.6 34.0  5.7 0.03
Carbohydrate intake (% energy intake) 44.1  6.3 46.6  6.5 , 0.01
Data are presented as mean  SD, percentage, or median (interquartile range). BMI, body mass index; DXA,
dual-energy X-ray absorptiometry; LDL, low-density lipoprotein; HDL, high-density lipoprotein; IGM, impaired
glucose metabolism; DM, diabetes mellitus. aPost load glucose was determined in 216 men and 211 women.
2342 Journal of Hypertension 2004, Vol 22 No 12
2), we did not include this measure in the mean Z-score
presented in Figure 3. Results including this measure
yielded similar results (data not shown).
Additional adjustment for heart rate did not influence
the association between body composition and carotid–
femoral TT (data not shown). Adjustment for lifestyle
measures did not affect any of the associations, nor did
adjustment for components of the metabolic syndrome
(LDL- and HDL-cholesterol, fasting and post-load glu-
cose, ln-transformed insulin, triglycerides, hyper-
tension) and other cardiovascular risk factors (serum
creatinine, (micro-) albuminuria, and prior cardio-
vascular disease). Model 2 shows the association ad-
justed for glucose tolerance status. None of the
regression models were disturbed by multi-colinearity.
Discussion
This study, in men and women aged 60–86 years, had
three major findings. First, larger trunk fat mass was
associated with higher peripheral, but not central,
arterial stiffness. Secondly, and in contrast, larger leg
fat mass was not associated with higher peripheral
arterial stiffness, but was instead associated with lower
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Table 2 Estimates of peripheral and central arterial stiffness
Men Women P
Peripheral arterial stiffnessa
Carotid artery
Distensibility coefficient (103/kPa) 12.30  4.47 11.42  4.55 0.03
Compliance coefficient (mm2/kPa) 0.65  0.25 0.48  0.18 , 0.01
Young’s elastic modulus (kPa) 0.92  0.49 0.98  0.57 0.28
Distension (m) 373  123 331  92 , 0.01
Diameter (mm) 8.35  1.10 7.48  0.97 , 0.01
Pulse pressure (mmHg) 58.7  13.3 65.1  17.9 , 0.01
Intima–media thickness (mm) 0.88  0.18 0.83  0.15 , 0.01
Femoral artery
Distensibility coefficient (103/kPa) 4.67  2.08 4.86  2.22 0.32
Compliance coefficient (mm2/kPa) 0.42  0.21 0.35  0.18 , 0.01
Distension (m) 207  75 209  74 0.78
Diameter (mm) 10.76  1.87 9.51  1.24 , 0.01
Pulse pressure (mmHg) 66.6  14.0 74.3  20.4 , 0.01
Brachial artery
Distensibility coefficient (103/kPa) 7.73  3.89 8.09  4.50 0.35
Compliance coefficient (mm2/kPa) 0.15  0.07 0.11  0.06 , 0.01
Distension (m) 152  69 142  66 0.10
Diameter (mm) 5.04  0.62 4.23  0.59 , 0.01
Pulse pressure (mmHg) 61.8  12.4 67.7  16.3 , 0.01
Central arterial stiffness
Carotid–femoral transit time (ms)b 55.8  16.8 52.0  16.1 0.08
Aortic augmentation index (%)c 144.9  19.1 156.5  18.5 , 0.01
Systemic arterial compliance (ml/mmHg)d 0.83  0.33 0.64  0.25 , 0.01
Systemic arterial compliance (ml/mmHg)e 1.19  0.34 0.93  0.30 , 0.01
Data are presented as mean  SD. a244 men and 240 women.b114 men and 121 women. c272 men and
270 women. d238 men and 253 women, estimated by time-decay method. e229 men and 245 women,
estimated by stroke volume-to-pulse pressure ratio.
Table 3 Associations (standardized betas) of body composition by DXA with peripheral arterial stiffness estimates
Carotid artery Femoral artery Brachial artery
DC CC E DC CC DC CC
Model 1 Trunk fat mass 0.15** 0.08* 0.15** 0.18** 0.26** 0.14** 0.16**
Leg fat mass 0.07 0.04 0.08 0.13** 0.22** 0.05 0.08
Leg lean mass 0.07 0.00 0.00 0.09 0.36** 0.06 0.14*
Model 2a Trunk fat mass 0.13** 0.07 0.14** 0.02 0.13** 0.05 0.09
Leg fat mass 0.04 0.02 0.07 0.02 0.13** 0.02 0.04
Leg lean mass 0.08 0.01 0.01 0.03 0.31** 0.09 0.12
All models are adjusted for age, height, sex, mean arterial pressure and the other two body composition variables. ** P , 0.05; * P , 0.10. DXA, dual-energy X-ray
absorptiometry; DC, distensibility coefficient; CC, compliance coefficient; E, Young’s elastic modulus. aModel 2 is Model 1 with additional adjustment for glucose
tolerance status.
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peripheral arterial stiffness, notably of the femoral
artery. Thirdly, larger leg lean mass was consistently,
and independently of trunk and leg fat mass, strongly
associated with lower central and less femoral and
brachial arterial stiffness. These results provide a
pathophysiological framework for understanding how
abdominal obesity may contribute to cardiovascular
disease, and how leg fat and lean mass may protect
against cardiovascular disease.
Results of previous studies on body composition and
arterial stiffness have not shown consistent results.
Most studies were performed with a relatively small
number of individuals (24–75) [16–19,21,24] and some
were restricted to children [20,21] or men only [16]. In
some studies measures of obesity (usually BMI) were
associated with higher arterial stiffness [16,19–23],
while other studies found the opposite [17,18,24]. The
present study has important advantages, because it was
large and population-based, and because comprehen-
sive measures of both peripheral and central arterial
stiffness were determined, as well as a very accurate
and precise measurement of body composition. The
latter is important because a higher BMI represents
larger fat as well as larger lean mass [9]. Because trunk
fat mass and leg (or trunk) lean mass have opposite
associations with arterial stiffness, the association of
BMI with arterial stiffness will depend on the extent to
which BMI reflects fat versus lean mass, and this may
explain the divergent results reported in previous stud-
ies.
Larger trunk fat mass was associated with higher
peripheral arterial stiffness in the elastic carotid artery
and the muscular femoral and brachial arteries. Adjust-
ment for glucose tolerance status did not materially
affect the associations with carotid artery stiffness, but
decreased those with femoral and brachial artery stiff-
ness (Table 3). This finding may indicate that the
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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Fig. 1
Independent associations (standardized betas, ) of body composition
variables, adjusted for each other, age, height, sex and mean arterial
pressure, with the mean Z-scores of all measures for peripheral arterial
stiffnessy. ** P , 0.01. (y Distensibility and compliance of the carotid,
femoral and brachial arteries and carotid Young’s elastic modulus.)
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Fig. 2
Independent associations (standardized betas, ) of body composition
variables, adjusted for each other, age, height, sex and mean arterial
pressure, with the mean Z-scores of measures for peripheral arterial
stiffnessy in each artery separately. ** P , 0.01. (y Distensibility and
compliance of the carotid, femoral and brachial arteries and carotid
Young’s elastic modulus.)
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association of trunk fat with femoral and brachial artery
stiffness is, in part, mediated by trunk-fat-induced
glucose intolerance. However, we cannot exclude con-
founding, because our study population was a sample
stratified for glucose tolerance status, and individuals
who are glucose intolerant have more trunk fat, on
average. Nevertheless, the concept that intra-abdominal
fat in particular contributes to hyperglycaemia and
hyperinsulinaemia, possibly due to an increased secre-
tion of free fatty acids (FFA) [1], is generally accepted.
Because DXA cannot distinguish between visceral and
subcutaneous trunk fat, additional studies are needed
to investigate the effect of subcutaneous fat, which is
the largest component of trunk fat, versus visceral fat
on peripheral arterial stiffness.
Several mechanisms can explain the relation between
abdominal obesity and arterial stiffness. Both insulin
and glucose levels attenuated some of the associations
we found in the present study, which supports the
concept that insulin and/or glucose levels may mediate
the relations between body composition and peripheral
arterial stiffness. Hyperinsulinaemia may promote en-
dothelial dysfunction, oxidative stress, vascular smooth
muscle cell growth, and stimulation of the sympathetic
nervous system [43], all of which may contribute to
arterial stiffness. Advanced glycation end-products can
form cross-links in collagen fibres, thereby decreasing
the distensibility of the arterial wall [44]. In addition,
inflammatory markers may also be mediators of the
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Table 4 Associations (standardized betas) of body composition measured by DXA with individual elements of the peripheral arterial
stiffness estimates
Carotid artery Femoral artery Brachial artery
D ˜D PP IMT D ˜D PP D ˜D PP
Model 1 Trunk fat mass 0.12** 0.07 0.06 0.02 0.17** 0.24** 0.04 0.02 0.13** 0.06
Leg fat mass 0.04 0.00 0.05 0.01 0.17** 0.23** 0.03 0.09* 0.05 0.03
Leg lean mass 0.12 0.01 0.01 0.13 0.41** 0.32** 0.01 0.36** 0.03 0.07
Model 2a Trunk fat mass 0.12** 0.07 0.03 0.04 0.17** 0.05 0.04 0.05 0.05 0.03
Leg fat mass 0.04 0.01 0.02 0.04 0.17** 0.11* 0.02 0.13** 0.01 0.00
Leg lean mass 0.10 0.02 0.01 0.14 0.41** 0.25** 0.01 0.37** 0.00 0.07
All models are adjusted for age, height, sex, mean arterial pressure and the other two body composition variables. ** P , 0.05, * P , 0.10. DXA, dual-energy X-ray
absorptiometry; D, diameter; ˜D, distension; PP, pulse pressure; IMT, intima–media thickness. aModel 2 is Model 1 with additional adjustment for glucose tolerance
status.
Table 5 Associations (standardized betas) of body composition by DXA with central
arterial stiffness estimates
Car-fem TT AI SAC1 SAC2
Model 1 Trunk fat mass 0.06 0.06 0.05 0.08*
Leg fat mass 0.14 0.06 0.08 0.09*
Leg lean mass 0.23** 0.15** 0.17** 0.30**
Model 2a Trunk fat mass 0.10 0.08 0.06 0.03
Leg fat mass 0.12 0.05 0.07 0.05
Leg lean mass 0.21* 0.15** 0.17** 0.29**
All models are adjusted for age, height, sex, mean arterial pressure and the other two body composition
variables. ** P , 0.05; * P , 0.10. DXA, dual-energy X-ray absorptiometry; Car–fem TT, carotid–femoral
transit time; AI, augmentation index; SAC1, systemic arterial compliance by time-decay method; SAC2
systemic arterial compliance by stroke volume-to-pulse pressure ratio. aModel 2 is Model 1 with additional
adjustment for glucose tolerance status.
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Independent associations (standardized betas, ) of body composition
variables, adjusted for each other, age, height, sex and mean arterial
pressure, with the mean Z-scores of measures for central arterial
stiffnessy. ** P, 0.01. (y Aortic augmentation index, systemic arterial
compliance by time decay method and systemic arterial compliance by
stroke volume-to-pulse pressure ratio.)
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relationships observed. These markers are increased in
obesity, and have been shown to relate to endothelial
dysfunction [45,46]. Finally, several other proteins
secreted by adipose tissue, such as resistin [47], adipo-
nectin [48] and leptin [20,49], have been shown to be a
possible link between obesity and vascular structure
and function.
Our finding that storage of fat in the legs may be
favourable for peripheral arterial stiffness provides a
potential explanation for the inverse relationship be-
tween hip circumference and cardiovascular risk [3–6].
The underlying mechanisms linking leg fat to (lower)
arterial stiffness remain to be identified. However, it is
becoming increasingly clear that leg fat is metabolically
different from trunk fat, and is associated with a more
favourable metabolic profile [7–9]. Leg fat has greater
lipolytic activity than fat in the abdominal region
[50,51], thus being able to take up FFA efficiently from
the circulation, thereby protecting against the develop-
ment of hyperglycaemia and hyperinsulinaemia [9,52].
In addition, leg fat and trunk fat may differ in secretion
of adipokines that influence vascular function and
structure. There are some known differences in secre-
tion of leptin, adiponectin and interleukin-6 between
abdominal subcutaneous and visceral fat [53–56], but
less is known about differences between abdominal and
femoral subcutaneous adipose tissue. Taken together,
we speculate that metabolic differences between leg
and trunk fat may be responsible for their opposite
associations with peripheral arterial stiffness. More
work in this area is clearly needed.
We found that leg lean (or muscle) mass was a more
important determinant of central arterial stiffness than
was fat mass. As muscle mass increases, so will the
requirements for blood supply, resulting in a higher
cardiac output and stroke volume and size adaptation of
the arteries. This is also demonstrated by the larger
diameter and distension of both femoral and brachial
arteries in people with more leg lean mass in our study.
The differences in the impact of body composition on
the various arterial stiffness estimates suggests that,
like the influence of ageing and other risk factors
[11,14], the impact of body composition is not uniform
along the arterial tree. Local differences in physiologi-
cal or mechanical mechanisms (e.g. between proximal
elastic versus peripheral muscular arteries) may play a
role [11,14].
The present study has some limitations. First, because
of the cross-sectional design of the study, we cannot
exclude the possibility that the associations between fat
distribution and arterial stiffness are caused by an
unmeasured common underlying factor. However, ad-
justment for many alternative determinants, such as
renal function, hypertension and lifestyle variables, did
not change our findings. Prospective studies are needed
to address this issue further. Secondly, because we
investigated an older Caucasian population, it is unclear
whether these results apply to younger subjects or other
ethnic populations. Finally, because of selective mortal-
ity and loss of follow-up of the unhealthiest subjects
(who are likely to have had increased fatness and
increased arterial stiffness), we probably have investi-
gated a relatively healthy population and therefore may
have underestimated the true associations (healthy
survivor effect).
We conclude that trunk fat has adverse effects on
peripheral, but not central, arterial stiffness. These
adverse effects are partly, but not completely, ex-
plained by hyperglycaemia and hyperinsulinaemia. In
contrast, peripheral fat mass was not harmful and may
possibly be slightly beneficial for peripheral arterial
stiffness. In addition, larger lean mass was strongly
associated with lower central arterial stiffness and lower
peripheral stiffness in the muscular arteries. These
results provide a pathophysiological framework to ex-
plain not only the higher cardiovascular risk in indivi-
duals with larger trunk fat mass, but also the reduced
cardiovascular risk in individuals with larger leg lean
and fat mass.
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